Concepedia

Mathilde Martinez

MM

Statistics

Publications

6

Citations

199

H-Index

6

Active since

1995

Affiliations

Groupe Hospitalier Diaconesses Croix Saint-Simon(Current)

Clinique Pasteur

Centre Jean Perrin

Centre François Baclesse

Centre Léon Bérard

Mathilde Martinez is an author at Groupe Hospitalier Diaconesses Croix Saint-Simon specializing in oncology, chemotherapy, and medicine.

ORCID

Publications per year

1995–2024

6

Publications

6

Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial

Jean‐Emmanuel Kurtz, Éric Pujade-Lauraine, Ana Oaknin et al. · Journal of Clinical Oncology · 2023 · 103 citations · Full text

, , +16

Neoadjuvant and adjuvant pembrolizumab in advanced high-grade serous carcinoma: the randomized phase II NeoPembrOV clinical trial

Isabelle Ray‐Coquard, Aude-Marie Savoye, Camille Schiffler et al. · Nature Communications · 2024 · 25 citations · Full text

, , +15

Irinotecan plus raltitrexed as first-line treatment in advanced colorectal cancer: a phase II study

Jaime Feliú, Antonieta Salud, P. Escudero et al. · British Journal of Cancer · 2004 · 24 citations · Full text

, , +12

Gemcitabine plus nab-paclitaxel until progression or alternating with FOLFIRI.3, as first-line treatment for patients with metastatic pancreatic adenocarcinoma: The Federation Francophone de Cancérologie Digestive-PRODIGE 37 randomised phase II study (FIRGEMAX)

Yves Rinaldi, Anne‐Laure Pointet, F. Khemissa Akouz et al. · European Journal of Cancer · 2020 · 18 citations

, , +15

A pharmacogically guided phase I study of carboplatin in combination with methotrexate and vinblastine in advanced urothelial cancer

Étienne Chatelut, Christine Chevreau, Valérie Brunner et al. · Cancer Chemotherapy and Pharmacology · 1995 · 17 citations

, , +11

1–5 of 6